Answer questions and earn CME/CNE Colorectal cancer (CRC) is the third most common
cancer and third leading cause of cancer death in both men and women and second leading …

Background New drug treatments, clinical trials, and standards of quality for assessment of
evidence justify an update of evidence-based recommendations for the pharmacological …

Purpose To provide evidence-based recommendations to update the American Society of
Clinical Oncology guideline on systemic therapy for stage IV non–small-cell lung cancer …

Adjuvant systemic therapy along with screening has been key to the observed
improvements in disease-free and overall survival (DFS/OS) in breast cancer. Improvements …

Neurotoxicity is a burdensome side effect of platinum-based chemotherapy that prevents
administration of the full efficacious dosage and often leads to treatment withdrawal …

Background. Chemotherapy with taxanes and platinum compounds has resulted in
substantial survival benefits both in adjuvant and metastatic settings. However, as a side …

Chemotherapy-induced peripheral neuropathy (CIPN) is a debilitating and painful condition
seen in patients undergoing treatment with common agents such as vincristine, paclitaxel …

Precise definition of CIPN clinical features can be obtained by only using validated outcome
measures. Therefore, a major aim of clinical research is to standardize CIPN assessment …

Although certain risk factors can identify individuals who are most likely to develop chronic
pain, few interventions to prevent chronic pain have been identified. To facilitate the …

Purpose: Taxane-induced peripheral neuropathy (TIPN) is an important survivorship issue
for many cancer patients. Currently, there are no clinically implemented biomarkers to …